Atom Research Alliance

Atom Research Alliance is a U.S.-based nonprofit public-benefit organization that operates the ATOM Consortium, a public-private collaboration focused on accelerating preclinical drug discovery. The organization develops and disseminates computational models, generative molecular design tools, and machine learning workflows intended to shorten lead optimization and improve multiparameter drug design. Its work emphasizes small-molecule discovery, integrating high-performance computing, biological data, simulation, and human-relevant experimentation in a precompetitive framework. Rather than advancing a traditional proprietary clinical pipeline, Atom Research Alliance appears to function as a platform and collaboration vehicle for open and shared drug-discovery infrastructure, publications, and software.